These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24970867)
1. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Wilkerson MD; Cabanski CR; Sun W; Hoadley KA; Walter V; Mose LE; Troester MA; Hammerman PS; Parker JS; Perou CM; Hayes DN Nucleic Acids Res; 2014 Jul; 42(13):e107. PubMed ID: 24970867 [TBL] [Abstract][Full Text] [Related]
2. A Computational Protocol for Detecting Somatic Mutations by Integrating DNA and RNA Sequencing. Wilkerson MD Methods Mol Biol; 2019; 1878():109-124. PubMed ID: 30378072 [TBL] [Abstract][Full Text] [Related]
3. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer. O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717 [TBL] [Abstract][Full Text] [Related]
4. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens. Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110 [TBL] [Abstract][Full Text] [Related]
5. Neoantigen prediction in human breast cancer using RNA sequencing data. Hashimoto S; Noguchi E; Bando H; Miyadera H; Morii W; Nakamura T; Hara H Cancer Sci; 2021 Jan; 112(1):465-475. PubMed ID: 33155341 [TBL] [Abstract][Full Text] [Related]
6. Identifying cancer driver genes in tumor genome sequencing studies. Youn A; Simon R Bioinformatics; 2011 Jan; 27(2):175-81. PubMed ID: 21169372 [TBL] [Abstract][Full Text] [Related]
7. Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations. Wolff A; Perera-Bel J; Schildhaus HU; Homayounfar K; Schatlo B; Bleckmann A; Beißbarth T Stud Health Technol Inform; 2018; 253():217-221. PubMed ID: 30147077 [TBL] [Abstract][Full Text] [Related]
8. RADIA: RNA and DNA integrated analysis for somatic mutation detection. Radenbaugh AJ; Ma S; Ewing A; Stuart JM; Collisson EA; Zhu J; Haussler D PLoS One; 2014; 9(11):e111516. PubMed ID: 25405470 [TBL] [Abstract][Full Text] [Related]
9. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038 [TBL] [Abstract][Full Text] [Related]
10. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations. Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829 [TBL] [Abstract][Full Text] [Related]
12. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256 [TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST). Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060 [TBL] [Abstract][Full Text] [Related]
14. Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel. Dufresne A; Attignon V; Ferrari A; Tonon L; Boyault S; Tabone-Eglinger S; Cassier P; Trédan O; Corradini N; Vinceneux A; Swalduz A; Viari A; Chabaud S; Pérol D; Blay JY; Saintigny P Cancer Med; 2024 Apr; 13(7):e7115. PubMed ID: 38553950 [TBL] [Abstract][Full Text] [Related]
15. Reliable identification of genomic variants from RNA-seq data. Piskol R; Ramaswami G; Li JB Am J Hum Genet; 2013 Oct; 93(4):641-51. PubMed ID: 24075185 [TBL] [Abstract][Full Text] [Related]
16. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing. Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040 [TBL] [Abstract][Full Text] [Related]
17. Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data. Coudray A; Battenhouse AM; Bucher P; Iyer VR PeerJ; 2018; 6():e5362. PubMed ID: 30083469 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes. Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH Oncotarget; 2017 Apr; 8(17):27997-28007. PubMed ID: 28427202 [TBL] [Abstract][Full Text] [Related]